{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:48:28Z","timestamp":1773290908384,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1067\/mhl.2003.27","type":"journal-article","created":{"date-parts":[[2003,5,13]],"date-time":"2003-05-13T05:27:45Z","timestamp":1052803665000},"page":"100-104","source":"Crossref","is-referenced-by-count":19,"title":["Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction"],"prefix":"10.1067","volume":"32","author":[{"given":"Florian H.","family":"Pilsczek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsad A.","family":"Karcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isreal","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhl.2003.27_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"NEJM"},{"key":"10.1067\/mhl.2003.27_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0736-4679(99)00176-6","article-title":"Myocardial infarction associated with phenylpropanolamine","volume":"18","author":"Oosterbaan","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1067\/mhl.2003.27_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0196-0644(96)70038-0","article-title":"Phenylpropanolamine and associated myocardial injury","volume":"28","author":"Leo","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mhl.2003.27_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/hrt.47.1.51","article-title":"Myocardial injury after phenylpropanolamine ingestion","volume":"47","author":"Pentel","year":"1982","journal-title":"Br Heart J"},{"key":"10.1067\/mhl.2003.27_bib5","first-page":"349","article-title":"Isch\u00e9mie myocardique aigu\u00eb apr\u00e8s prise d'un vasoconstricteur","volume":"41","author":"Ferrari","year":"1992","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1067\/mhl.2003.27_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0002-9343(90)90299-S","article-title":"Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reports","volume":"89","author":"Lake","year":"1990","journal-title":"Am J Med"},{"key":"10.1067\/mhl.2003.27_bib7","first-page":"575","article-title":"Phenylpropanolamine and caffeine use among diet center clients","volume":"14","author":"Lake","year":"1990","journal-title":"Int J Obes"},{"key":"10.1067\/mhl.2003.27_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5993\/AJHB.25.2.4","article-title":"Weight loss behaviors and smoking in college students of diverse ethnicity","volume":"25","author":"George","year":"2001","journal-title":"Am J Health Behav"},{"key":"10.1067\/mhl.2003.27_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3949\/ccjm.68.3.208","article-title":"Phenylpropanolamine and stroke: The study, the FDA ruling, the implications","volume":"68","author":"Mersfelder","year":"2001","journal-title":"Cleveland Clin J Med"},{"key":"10.1067\/mhl.2003.27_bib11","unstructured":"Martindale. The complete drug reference. 33rd ed\/edited by Sean C. Sweetman. Pharmaceutical Press, London 2002 (online version accessed 11\/02)."},{"key":"10.1067\/mhl.2003.27_NEWBIB1","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1097\/00003246-200011000-00024","article-title":"Inhibition of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine","volume":"28","author":"Zaloga","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1067\/mhl.2003.27_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(89)90341-0","article-title":"Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: A placebo controlled follow-up study","volume":"86","author":"Lake","year":"1989","journal-title":"Am J Med"},{"key":"10.1067\/mhl.2003.27_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1227\/00006123-198706000-00027","article-title":"Phenylpropanolamine: An over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review","volume":"20","author":"Glick","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1067\/mhl.2003.27_bib15","first-page":"729","article-title":"Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule","volume":"119","author":"Chouinard","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1067\/mhl.2003.27_bib16","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.1984.03350140044023","article-title":"Toxicity of over-the-counter stimulants","volume":"252","author":"Pentel","year":"1984","journal-title":"JAMA"},{"key":"10.1067\/mhl.2003.27_bib17","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1096\/fasebj.3.9.2545495","article-title":"Endothelium-derived relaxing and contracting factors","volume":"3","author":"Furchgott","year":"1989","journal-title":"FASEB J"},{"key":"10.1067\/mhl.2003.27_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0083-6729(08)60639-1","article-title":"Nitric oxide and platelet aggregation","volume":"57","author":"Riddell","year":"1999","journal-title":"Vitam Horm"},{"key":"10.1067\/mhl.2003.27_bib19","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI117852","article-title":"Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis","volume":"95","author":"Quyyumi","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1067\/mhl.2003.27_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM199105303242203","article-title":"Impairment of endothelium dependent pulmonary artery relaxation in chronic obstructive lung disease","volume":"324","author":"Dinh-Xuan","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mhl.2003.27_bib21","volume":"Vol 114","author":"Micromedex","year":"1974","journal-title":"Thomson Micromedex"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956303000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956303000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T07:25:59Z","timestamp":1539674759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956303000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0147956303000359"],"URL":"https:\/\/doi.org\/10.1067\/mhl.2003.27","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}